| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d7e2f8fb5650d7d3616661464b67771 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b168e38b88091a08a8ef06e5c5d8ff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cf76406c97c582d9f98e3e81e501259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af1f8aba81b23a312c9edb3207465348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_969ce45c5c90f540a09fc8d0404ac88d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_602baf2bbad1cbf64aa14e53ce755a84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20c16a86796bd604db6357c62bc9e9a7 |
| publicationDate |
2016-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016091168-A1 |
| titleOfInvention |
Quinoline derivative against non-small cell lung cancer |
| abstract |
Provided in the present application is a quinoline derivative against non-small cell lung cancer. 1-[[[4-(4-fluoro-2-methyl-1H-indole-5-yl)oxy-6-methoxyquinoline-7-yl]oxy]methyl]cyclopropylamine or a pharmaceutically acceptable salt thereof as provided in the present application can be used for treating non-small cell lung cancer, and with respect to placebos, can significantly increase the progression-free survival of a patient with non-small cell lung cancer. The 1-[[[4-(4-fluoro-2-methyl-1H-indole-5-yl)oxy-6-methoxyquinoline-7-yl]oxy]methyl]cyclopropylamine or a pharmaceutically acceptable salt thereof as provided in the present application can be used for treating lung adenocarcinoma, and with respect to placebos, can significantly increase the progression-free survival of a patient with lung adenocarcinoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020057536-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112638385-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112638385-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736887-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10730878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10888559-B2 |
| priorityDate |
2014-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |